JP2020518555A5 - - Google Patents

Info

Publication number
JP2020518555A5
JP2020518555A5 JP2019552993A JP2019552993A JP2020518555A5 JP 2020518555 A5 JP2020518555 A5 JP 2020518555A5 JP 2019552993 A JP2019552993 A JP 2019552993A JP 2019552993 A JP2019552993 A JP 2019552993A JP 2020518555 A5 JP2020518555 A5 JP 2020518555A5
Authority
JP
Japan
Prior art keywords
methyl
oxadiazole
dihydro
fluorophenyl
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019552993A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020518555A (ja
JP7227916B2 (ja
Filing date
Publication date
Priority claimed from EP17169277.5A external-priority patent/EP3398941A1/en
Application filed filed Critical
Publication of JP2020518555A publication Critical patent/JP2020518555A/ja
Publication of JP2020518555A5 publication Critical patent/JP2020518555A5/ja
Application granted granted Critical
Publication of JP7227916B2 publication Critical patent/JP7227916B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019552993A 2017-05-03 2018-05-02 複素環p2x7アンタゴニスト Active JP7227916B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17169277.5 2017-05-03
EP17169277.5A EP3398941A1 (en) 2017-05-03 2017-05-03 Heterocyclic p2x7 antagonists
PCT/EP2018/061180 WO2018202694A1 (en) 2017-05-03 2018-05-02 Heterocyclic p2x7 antagonists

Publications (3)

Publication Number Publication Date
JP2020518555A JP2020518555A (ja) 2020-06-25
JP2020518555A5 true JP2020518555A5 (enExample) 2022-10-06
JP7227916B2 JP7227916B2 (ja) 2023-02-22

Family

ID=58668805

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019552993A Active JP7227916B2 (ja) 2017-05-03 2018-05-02 複素環p2x7アンタゴニスト

Country Status (10)

Country Link
US (1) US11623919B2 (enExample)
EP (2) EP3398941A1 (enExample)
JP (1) JP7227916B2 (enExample)
CN (1) CN110770214B (enExample)
CA (1) CA3059525A1 (enExample)
DK (1) DK3619200T3 (enExample)
ES (1) ES2911049T3 (enExample)
IL (1) IL270275B2 (enExample)
RU (1) RU2768865C2 (enExample)
WO (1) WO2018202694A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116782901A (zh) 2020-11-30 2023-09-19 旭化成制药株式会社 用于使神经病理性疼痛缓和的药物
US20240368092A1 (en) 2021-09-03 2024-11-07 Breye Therapeutics Aps 2,4-Dihydro-3H-1,2,4-Triazol-3-One P2X7 Antagonists
WO2025057074A1 (en) 2023-09-13 2025-03-20 Suven Life Sciences Limited N-aryl benzamide derivatives as p2x7 receptor antagonists
WO2026041663A1 (en) 2024-08-22 2026-02-26 Breye Therapeutics Aps P2x7 receptor antagonists

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1529621A (fr) * 1967-01-17 1968-06-21 Dausse Lab Nouvelles oxadiazolinones basiques et leur procédé de préparation
FR1529700A (fr) * 1967-04-11 1968-06-21 Dausse Sa Lab Tertioaminoalcoyl oxadiazolinones et leur procédé de préparation
FR1575552A (enExample) * 1967-12-07 1969-07-25
GB1508210A (en) 1975-12-22 1978-04-19 Labaz Benzofuran-derived amidoximes and process for preparing the same
JPS61106575A (ja) * 1984-10-31 1986-05-24 Nippon Soda Co Ltd 1,2,4−チアジアゾ−ル−5−オン誘導体及び製造方法
US5066662A (en) * 1990-05-21 1991-11-19 Warner-Lambert Company Substituted oxazolidin-2-ones and 1,2,4-oxadiazolin-5-ones and derivatives thereof acting at muscarinic receptors
ATE295832T1 (de) 2000-03-24 2005-06-15 Pharmacia Corp Amidino-verbindung sowie salze davon verwendbar als hemmstoffe der stickstoffmonoxid-synthase
AR034120A1 (es) 2000-04-13 2004-02-04 Pharmacia Corp Compuesto derivado halogenado del acido 2-amino-4,5 heptenoico, composicion farmaceutica que lo comprende y el uso de dicho compuesto y dicha composicion en la fabricacion de un medicamento para inhibir o modular la sintesis de acido nitrico
TWI290130B (en) 2000-09-15 2007-11-21 Pharmacia Corp 2-Amino-2alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
AR031129A1 (es) 2000-09-15 2003-09-10 Pharmacia Corp Derivados de los acidos 2-amino-2-alquil-4-hexenoico y -hexinoico utiles como inhibidores de oxido nitrico sintetasa
ES2281801T3 (es) 2003-05-12 2007-10-01 Pfizer Products Inc. Inhibidores benzamida del receptor p2x7.
GB0312609D0 (en) 2003-06-02 2003-07-09 Astrazeneca Ab Novel compounds
EP2215086B1 (en) * 2007-11-20 2011-08-24 Sumitomo Chemical Company, Limited Pyridine compound, pesticidal composition and method of controlling pest
KR100967889B1 (ko) * 2008-02-01 2010-07-06 한국화학연구원 2-이미노벤조이미다졸 유도체를 포함하는 살균제 조성물
WO2009108551A2 (en) 2008-02-25 2009-09-03 H. Lundbeck A/S Heteroaryl amide analogues
KR101598397B1 (ko) 2008-04-22 2016-02-29 얀센 파마슈티카 엔.브이. 퀴놀린 또는 이소퀴놀린 치환된 피2엑스7 안타고니스트
PL213249B1 (pl) * 2009-12-08 2013-02-28 Univ Medyczny W Lublinie Zastosowanie pochodnych semikarbazydowych oraz 1,2,4-triazolino-5-onu posiadających układ 1-metylopirolu
JP2012041325A (ja) * 2010-08-23 2012-03-01 Bayer Cropscience Ag オキサジアゾリノン誘導体およびその有害生物の防除用途
US9988373B2 (en) 2013-12-26 2018-06-05 Shionogi & Co., Ltd. Nitrogen-containing six-membered cyclic derivatives and pharmaceutical composition comprising the same
JP6285736B2 (ja) 2014-02-04 2018-02-28 株式会社ソニー・インタラクティブエンタテインメント 情報処理装置および入力デバイスの割当方法

Similar Documents

Publication Publication Date Title
JP6655742B2 (ja) ピペリジンcxcr7受容体調節剤
CA2483159C (en) Triazole derivatives as tachykinin receptor antagonists
ES2581565T3 (es) Aminotriazolopiridinas y su uso como inhibidores de cinasas
AU2012210489B2 (en) IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation
JP2019077725A5 (enExample)
JP2007510689A5 (enExample)
IL258577A (en) 2,4-dihydroxy-nicotinamides as apj agonists
RU2012116207A (ru) Производные индола в качестве модуляторов crac
RU2011116226A (ru) Пиразолопиридиновые производные как ингибиторы надфн-оксидазы
JP2018519323A5 (enExample)
HRP20201746T1 (hr) Aromatski derivati sulfonamida
JP2018530591A5 (enExample)
JP5602230B2 (ja) スフィンゴシン−1−リン酸受容体アゴニスト
RU2014107463A (ru) Селективные ингибиторы протеинкиназ
JP2017532364A5 (enExample)
JP2018507235A5 (enExample)
RU2015144386A (ru) Циклоалкилнитрилпиразолопиридоны в качестве ингибиторов янус-киназы
RU2019134453A (ru) Гетероциклические антагонисты Р2Х7
JP2022505707A5 (enExample)
JP2021501216A5 (enExample)
KR101706486B1 (ko) 우울증, 당뇨병 및 파킨슨병과 같은 몇가지 장애의 치료에 사용하기 위한 taar 조절제로서의 피라졸 카복스아마이드 유도체
US12344600B2 (en) c-Myc mRNA translation modulators and uses thereof in the treatment of cancer
JP2016527300A5 (enExample)
AU2013397913A1 (en) Substituted imidazoles as N-type calcium channel blockers
AR112183A1 (es) Oxadiazoles fungicidas